Human glucocorticoid receptor β regulates gluconeogenesis and inflammation in mouse liver

Molecular and Cellular Biology

Volumn 36, Issue 5, 2016, Pages 714-730

  He, Bo ^a   Cruz Topete, Diana ^a   Oakley, Robert H ^a   Xiao, Xiao ^b   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; HUMAN GLUCOCORTICOID RECEPTOR BETA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STAT1 PROTEIN; UNCLASSIFIED DRUG; GLUCOCORTICOID RECEPTOR; STAT1 PROTEIN, MOUSE;

ADENO ASSOCIATED VIRUS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC ASSOCIATION; GLUCONEOGENESIS; INFLAMMATION; LIVER CELL; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; METABOLISM;

ANIMALS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GLUCONEOGENESIS; HUMANS; INFLAMMATION; LIVER; MICE; MICE, INBRED C57BL; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; STAT1 TRANSCRIPTION FACTOR;

EID: 84961201542     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00908-15     Document Type: Article

References (35)

1. Lu NZ, Cidlowski JA. 2005. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18:331-342. http://dx.doi.org/10.1016/j .molcel.2005.03.025.
2. Oakley RH, Cidlowski JA. 2011. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 286:3177-3184. http://dx.doi.org /10.1074/jbc.R110.179325.
3. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635-641. http://dx.doi.org/10.1038/318635a0.
4. Kino T, Su YA, Chrousos GP. 2009. Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 66:3435-3448. http://dx.doi .org/10.1007/s00018-009-0098-z.
5. Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA. 1999. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Chem 274:27857- 27866.
6. Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GP. 2009. Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem Biophys Res Commun 381:671-675. http://dx.doi.org/10.1016/j.bbrc.2009.02.110.
7. Lewis-Tuffin LJ, Cidlowski JA. 2006. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 1069:1-9. http://dx.doi.org/10.1196/annals.1351.001.
8. Webster JC, Oakley RH, Jewell CM, Cidlowski JA. 2001. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A 98:6865- 6870. http://dx.doi.org/10.1073 /pnas.121455098.
9. Derijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, de Kloet ER, Emery P, Sternberg EM, Detera-Wadleigh SD. 2001. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 28:2383-2388.
10. van den Akker EL, Koper JW, van Rossum EF, Dekker MJ, Russcher H, de Jong FH, Uitterlinden AG, Hofman A, Pols HA, Witteman JC, Lamberts SW. 2008. Glucocorticoid receptor gene and risk of cardiovascular disease. Arch Intern Med 168:33-39. http://dx.doi.org/10.1001 /archinternmed.2007.41.
11. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA. 2007. Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active. Mol Cell Biol 27:2266-2282. http://dx.doi.org/10.1128 /MCB.01439-06.
12. Xiao X, Li J, Samulski RJ. 1998. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224-2232.
13. Ayuso E, Mingozzi F, Montane J, Leon X, Anguela XM, Haurigot V, Edmonson SA, Africa L, Zhou S, High KA, Bosch F, Wright JF. 2010. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther 17:503-510. http://dx .doi.org/10.1038/gt.2009.157.
14. Oakley RH, Ren R, Cruz-Topete D, Bird GS, Myers PH, Boyle MC, Schneider MD, Willis MS, Cidlowski JA. 2013. Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease. Proc Natl Acad Sci U S A 110:17035-17040. http://dx.doi.org/10.1073 /pnas.1302546110.
15. Oakley RH, Webster JC, Sar M, Parker CR, Jr, Cidlowski JA. 1997. Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology 138:5028-5038.
16. Yudt MR, Jewell CM, Bienstock RJ, Cidlowski JA. 2003. Molecular origins for the dominant negative function of human glucocorticoid receptor beta. Mol Cell Biol 23:4319-4330. http://dx.doi.org/10.1128/MCB .23.12.4319-4330.2003.
17. Whirledge S, Xu X, Cidlowski JA. 2013. Global gene expression analysis in human uterine epithelial cells defines new targets of glucocorticoid and estradiol antagonism. Biol Reprod 89:66. http://dx.doi.org/10.1095 /biolreprod.113.111054.
18. Kay MA. 2011. State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet 12:316-328. http://dx.doi.org/10.1038/nrg2971.
19. Mingozzi F, High KA. 2011. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 12:341-355. http://dx.doi.org/10.1038/nrg2988.
20. Duma D, Collins JB, Chou JW, Cidlowski JA. 2010. Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence. Sci Signal 3:ra74. http://dx.doi.org/10 .1126/scisignal.2001077.
21. Yabaluri N, Bashyam MD. 2010. Hormonal regulation of gluconeogenic gene transcription in the liver. J Biosci 35:473-484. http://dx.doi.org/10 .1007/s12038-010-0052-0.
22. Hu X, Li WP, Meng C, Ivashkiv LB. 2003. Inhibition of IFN-gamma signaling by glucocorticoids. J Immunol 170:4833-4839. http://dx.doi .org/10.4049/jimmunol.170.9.4833.
23. Flammer JR, Dobrovolna J, Kennedy MA, Chinenov Y, Glass CK, Ivashkiv LB, Rogatsky I. 2010. The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol Cell Biol 30:4564-4574. http: //dx.doi.org/10.1128/MCB.00146-10.
24. Piessevaux J, Lavens D, Peelman F, Tavernier J. 2008. The many faces of the SOCS box. Cytokine Growth Factor Rev 19:371-381. http://dx.doi.org /10.1016/j.cytogfr.2008.08.006.
25. Oakley RH, Cidlowski JA. 2013. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol 132:1033-1044. http://dx.doi.org/10.1016/j.jaci.2013.09.007.
26. So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR. 2007. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3:e94. http://dx.doi.org/10.1371/journal .pgen.0030094.
27. Bessis N, GarciaCozar FJ, Boissier MC. 2004. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther 11(Suppl 1):S10 -S17. http://dx.doi.org/10.1038/sj.gt.3302364.
28. Li LB, Leung DY, Hall CF, Goleva E. 2006. Divergent expression and function of glucocorticoid receptor beta in human monocytes and T cells. J Leukoc Biol 79:818-827. http://dx.doi.org/10.1189/jlb.0805466.
29. Zhang X, Clark AF, Yorio T. 2005. Regulation of glucocorticoid responsiveness in glaucomatous trabecular meshwork cells by glucocorticoid receptor- beta. Invest Ophthalmol Vis Sci 46:4607-4616. http://dx.doi.org /10.1167/iovs.05-0571.
30. Charmandari E, Chrousos GP, Ichijo T, Bhattacharyya N, Vottero A, Souvatzoglou E, Kino T. 2005. The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes. Mol Endocrinol 19:52-64. http://dx.doi.org/10.1210/me.2004-0112.
31. de Guia RM, Rose AJ, Herzig S. 2014. Glucocorticoid hormones and energy homeostasis. Horm Mol Biol Clin Investig 19:117-128. http://dx .doi.org/10.1515/hmbci-2014-0021.
32. Hinds TD, Jr, Ramakrishnan S, Cash HA, Stechschulte LA, Heinrich G, Najjar SM, Sanchez ER. 2010. Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol Endocrinol 24:1715-1727. http: //dx.doi.org/10.1210/me.2009-0411.
33. Zhu J, Huang X, Yang Y. 2009. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest 119:2388-2398. http://dx.doi.org/10.1172 /JCI37607.
34. McCaffrey AP, Fawcett P, Nakai H, McCaffrey RL, Ehrhardt A, Pham TT, Pandey K, Xu H, Feuss S, Storm TA, Kay MA. 2008. The host response to adenovirus, helper-dependent adenovirus, and adenoassociated virus in mouse liver. Mol Ther 16:931-941. http://dx.doi.org /10.1038/mt.2008.37.
35. Gross KL, Cidlowski JA. 2008. Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol Metab 19:331-339. http://dx.doi.org/10 .1016/j.tem.2008.07.009.